Kestra Advisory Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $383K | Sell |
|
|||||
|
2025
Q1 | $435K | Sell |
|
|||||
|
2024
Q4 | $472K | Buy |
|
|||||
|
2024
Q3 | $329K | Sell |
|
|||||
|
2024
Q2 | $319K | Sell |
|
|||||
|
2024
Q1 | $363K | Buy |
|
|||||
|
2023
Q4 | $366K | Sell |
|
|||||
|
2023
Q3 | $363K | Buy |
|
|||||
|
2023
Q2 | $374K | Sell |
|
|||||
|
2023
Q1 | $433K | Sell |
|
|||||
|
2022
Q4 | $439K | Sell |
|
|||||
|
2022
Q3 | $413K | Buy |
|
|||||
|
2022
Q2 | $399K | Buy |
|
|||||
|
2022
Q1 | $336K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $206K | Buy |
|